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Abstract: Neurophysiological measures of preparation and attention are often atypical in ADHD. Still,
replicated findings that these measures predict which patients improve after Neurofeedback (NF), reveal
neurophysiological specificity, and reflect ADHD-severity are limited. METHODS We analyzed children’s
preparatory (CNV) and attentional (Cue-P3) brain activity and behavioral performance during a cued
Continuous Performance Task (CPT) before and after slow cortical potential (SCP)-NF or semi-active
control treatment (electromyogram biofeedback). Mixed-effects models were performed with 103 partici-
pants at baseline and 77 were assessed for pre-post comparisons focusing on clinical outcome prediction,
specific neurophysiological effects of NF, and associations with ADHD-severity. RESULTS Attentional
and preparatory brain activity and performance were non-specifically reduced after treatment. Prepara-
tory activity in the SCP-NF group increased with clinical improvement. Several performance and brain
activity measures predicted non-specifictreatment outcome. CONCLUSION Specific neurophysiologi-
cal effects after SCP-NF were limited to increased neural preparation associated with improvement on
ADHD-subscales, but several performance and neurophysiological measures of attention predicted treat-
ment outcome and reflected symptom severity in ADHD. The results may help to optimize treatment.
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 ADHD symptom severity rated by parents was associated with a lower Cue-P3 and 
neurophysiological markers of attention. 
 Teachers rating was associated only with behavioral markers of attention, such as hit 
rate, reaction time, and reaction time variability 
 Several CPT performance and activity measures predicted treatment outcome  
 Better treatment outcome was associated with increased CNV amplitude only after 
SCP-NF. 




Neurophysiological measures of preparation and attention are often atypical in ADHD. Still, 
replicated findings that these measures predict which patients improve after Neurofeedback 
(NF), reveal neurophysiological specificity, and reflect ADHD-severity are limited. 
Methods 
We analyzed children’s preparatory (CNV) and attentional (Cue-P3) brain activity and 
behavioral performance during a cued Continuous Performance Task (CPT) before and after 
slow cortical potential (SCP)-NF or semi-active control treatment (electromyogram 
biofeedback). Mixed-effects models were performed with 103 participants at baseline and 77 
were assessed for pre-post comparisons focusing on clinical outcome prediction, specific 
neurophysiological effects of NF, and associations with ADHD-severity.  
Results 
Attentional and preparatory brain activity and performance were non-specifically reduced after 
treatment. Preparatory activity in the SCP-NF group increased with clinical improvement. 
Several performance and brain activity measures predicted non-specifictreatment outcome. 
Conclusion 
Specific neurophysiological effects after SCP-NF were limited to increased neural preparation 
associated with improvement on ADHD-subscales, but several performance and 
neurophysiological measures of attention predicted treatment outcome and reflected symptom 
severity in ADHD. The results may help to optimize treatment. 
Keywords: Neurofeedback; Slow Cortical Potentials, SCP; Randomized Controlled Trial; 
Attention-Deficit/Hyperactivity Disorder (ADHD); sustained attention; response control; 
Continuous Performance Test, CPT; Contingent Negative Variation, CNV; Cue-P3; Event 













Attention-deficit hyperactivity disorder (ADHD), one of the most prevalent childhood 
psychiatric disorders (Polanczyk, Salum, Sugaya, Caye, & Rohde, 2015), is characterized by 
the core symptoms of inattention and hyperactivity/impulsivity. Children with ADHD are 
significantly impaired in their daily functioning at home and in school, and the problems often 
persist in adulthood (for a review see Franke et al. (2018)). 
Comparisons between participants with and without ADHD show differences in oscillatory 
brain activity (Barry, Clarke, & Johnstone, 2003) and event-related potentials (ERP) (Albrecht 
et al., 2013; Doehnert, Brandeis, Schneider, Drechsler, & Steinhausen, 2013). Atypical activity 
in ERP components in ADHD is associated with inhibition, preparation, and attention 
orientation (Kaiser et al., 2020). Although these differences between groups are not sufficiently 
validated and robust to serve as markers for diagnosis, they  might have prognostic value (Arns, 
Heinrich, & Strehl, 2014). For example, previous studies showed that excess theta activity was 
associated with favorable treatment response to stimulant medication (Ogrim et al., 2014) and 
EEG-neurofeedback (Arns, Drinkenburg, & Leon Kenemans, 2012; Gevensleben et al., 2009).  
Non-pharmacological treatment options which refer to the neurophysiological deviations, such 
as neurofeedback (NF) may ameliorate the ADHD core symptoms, especially for proximal 
raters. Several meta-analyses reported significantly higher symptom reduction compared to 
passive or semi-active control groups (for details see Bussalb et al., 2019; Catala-Lopez et al., 
2017). However, there is still a debate regarding the specificity of NF treatments, and the 
limited effects seen by probably blinded raters despite more promising effects for standard NF 
protocols including slow cortical potential (SCP) NF (Cortese et al., 2016).  
NF aims at learning to self-regulate certain parameters of the neurophysiological brain activity 
by means of EEG biofeedback. The rationale for improving the core symptoms of ADHD 
through NF is based on training self-regulation of neurophysiological parameters such as 
theta/beta, SMR, or SCPs, which are associated with the regulation of alertness, attention, and 
behavioral control. A recent meta-analysis of ERPs in ADHD showed significant deviation in 
late cognitive processes associated ERPs, such as Cue-P3, NoGo-P3, and contingent negative 
variation (CNV) amplitudes (Kaiser et al., 2020). 
In this randomized controlled trial (RCT) we investigated the clinical effects of SCP-NF 
training, the predictive value of ERPs associated with attention and preparation, and the 
neurophysiological changes after treatment end. The primary clinical outcome showed 
superiority of SCP-NF in comparison to a semi-active control group one month after treatment 
end, but this effect was lost at six-month follow-up (Aggensteiner et al., 2019; Strehl et al., 
2017) which was due to an improvement in the control group. Concerning the effects on 
attention at a neurophysiological level, a main target of SCP-NF is the CNV which is an event-
related slow cortical potential reflecting expectation and cognitive anticipation or motor 
preparation. The CNV was found to be reduced in children with ADHD (Banaschewski et al., 
2003), which was recently confirmed by a meta-analysis showing that the CNV was lower in 
ADHD with a medium pooled effect size (Kaiser et al., 2020). This is in line with models 
supposing a dysfunctional regulation of energetical resources in ADHD (Sergeant, 2000).  
Several studies have investigated the impact of SCP-NF on the CNV during a cued continuous 
performance task (CPT) probing attention and anticipation as well as inhibition. Heinrich, 










CNV amplitude while no increase was found in the waiting-list group. This CNV increase was 
interpreted as a neurophysiological equivalent of improved self-regulation capabilities. A 
significant correlation between SCP regulation and changes of the CNV amplitude was found 
by Doehnert, Brandeis, Straub, Steinhausen, and Drechsler (2008). Interestingly, a later study 
replicated the specific effects of SCP-NF training on the CNV during a cued CPT in a sample 
of 56 children (Wangler et al., 2011). The predictive value of these attention-associated 
markers was less systematically studied. For instance, Gevensleben et al. (2009) showed that 
alpha oscillations were associated with clinical change and Wangler et al. (2011) reported that 
the baseline CNV predicted treatment outcome after SCP-NF. For this reason, we focus on the 
CNV, which is also closely related to the slow cortical negativity targeted by the SCP-NF 
training used here.  
Changes of P300 components may also be promising for predicting treatment effects in 
children with ADHD. The Go-P3 may be rather, in contrast to CNV, associated with unspecific 
treatment effects also present after an attention skills training (Wangler et al, 2011), while 
elevated Nogo-P3 was found in another study after frequency-band NF in good but not poor 
performers (Kropotov et al. 2005). Unfortunately, the CPT conducted in the current study 
yielded considerably lower numbers of Go- and NoGo- compared to Cue trials which prevented 
analysing these P300 components in the current study. 
In the present multi-level investigation, we explored the associations between behavioral 
ratings and neuropsychological and -physiological parameters of CPT performance. Second, 
we evaluated these parameters regarding unspecific and specific effects of SCP-NF in 
comparison to electromyogram biofeedback (EMG-BF) and their unspecific and specific 
predictive value regarding treatment outcome.  
We hypothesized that CPT performance and attentional and preparatory neurophysiological 
activity to Cues are associated with symptom severity and can predict clinical outcome. We 
expected specific treatment effects in terms of enhanced CPT performance and Cue-P3 and 
CNV amplitudes following SCP-NF compared to EMG-BF (Heinrich et al., 2004; Wangler et 
al., 2011).  
Methods 
Sample 
The current analysis dwells on the association of ADHD symptoms with performance and 
neurophysiological measures of attention and preparation during the Continuous Performance 
Test (CPT) to gain insights into mechanisms of training-induced improvements. Patients with 
ADHD combined type according to DSM-IV TR aged 7 to 9 years were recruited and treated 
by five German child and adolescent psychiatry outpatient clinics. The diagnosis was verified 
in a semi-structured clinical interview (Delmo, Weifenbach, Gabriel, Stadler, & Poustka, 
1998). The impact of Neurofeedback and EMG-Feedback on ADHD symptom ratings by 
parents and teachers using the FBB-HKS, and comorbid symptoms as measured by the 
Strengths and Difficulties Questionnaire (SDQ by Goodman (1997) with German norms by 












The multicenter intervention study was conducted according to the declaration of Helsinki as 
a randomized controlled trial comparing SCP-Neurofeedback with EMG-Biofeedback 
(ISRCTN76187185). For SCP-Neurofeedback, the EEG was registered at electrode CZ with 
reference to the left mastoid, real-time-preprocessing included ocular correction, artifact 
rejection, and filtering. EMG-Biofeedback was obtained from two electrodes placed at the 
upper shoulder area for addressing contraction or relaxation of the left to right musculus 
supraspinatus. Both SCP and EMG signals were fed back visually including positive 
reinforcers if a pre-defined regulation criterion was fulfilled.  
Both interventions were administered within three months at the outpatient clinics by trained 
instructors and comprised 25 sessions of four blocks with 40 trials each and were identical in 
terms of transfer trials, feedback presentation, reinforcement schedules and electrode montage. 
The general study protocol with further details and primary study outcome is described in 
previous publications (Holtmann, Pniewski, Wachtlin, Worz, & Strehl, 2014; Strehl et al., 
2017, Aggensteiner et al., 2019) (see Figure 1a). 
########################################################################### 




The cued CPT modeled after Rosvold, Mirsky, Sarason, Bransome, and Beck (1956) comprises 
a sequence of 400 letters presented for 150 ms with a stimulus onset asynchrony of 1650 ms. 
These include N=80 Cues (“O”), N=80 targets (“X”), N= 80 frequent distractors (“H”) and 
further N=160 distractors (letters B, C, D, F, G, H, J, L with equal probability each). The 
sequences cued Targets (“O-X” that requires responding) and cued Non-Targets (“O” followed 
by another letter than “X” that requires not responding) were presented pseudo-randomized 40 
times each (see Figure 1b). 
 
EEG Recording and Processing 
During CPT performance, the EEG was continuously recorded from 19 sites of a 10-20 
montage and additional electrodes for a vertical and horizontal electro-oculogram with a 
reference and ground electrode placed at the right and left mastoid via Ag/AgCl ring electrodes 
and Abralyt ™ electrode cream using TheraPrax ™ amplifiers (neuroConn GmbH, Ilmenau, 
Germany). The signals were registered from DC to 150 Hz and sampled at 512 Hz. 
Offline processing was performed with Brain Vision Analyzer 2.2.0 (BrainProducts, Gilching 
Germany). The continuous EEG was filtered with 0.1 to 30 Hz, 24 db/oct Butterworth filters, 
broad artefacts were eliminated after visual inspection and heavily affected channels were 











removed as described by Gratton, Coles, and Donchin (1983). Data were re-referenced to the 
average reference and subsequently checked for remaining artefacts. If amplitudes at any 
channels exceeded ±150µV, a segment -150ms to 800ms was discarded. The continuous data 
were segmented -200 to 1800 ms around correctly processed Cues; all averages contained at 
least 10 sweeps. The Cue-P3 was detected as the most positive peak between 300 and 750ms, 
and the Cue-CNV was quantified as the mean activity 1200 to 1650 ms following Cue and 
Distractor onset.  
 
Available EEG Samples  
From the total sample of N=132 patients that received either SCP-NF or EMG-BF, 109 had 
CPT EEG data from the Pre-assessment for analysis of baseline associations between 
behavioral ratings, CPT performance, and neurophysiological characteristics of Cue-
processing. After excluding participants with artefacts in the EEG or poor performance (more 
than 50% omission or commission errors), EEG data of N=103 patients at Pre-assessment (74% 
of the total sample) was analyzed (which is included in the association and prediction analyses 
as long as behavioral ratings were also available; see the descriptive statistics in Table 1 and 
Figure 1c). 
########################################################################### 
Insert Table 1 about here 
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Altogether 89 subjects also participated in CPT-assessments at Post-2, of which 77 (58 % of 
the total sample) had acceptable electrophysiological data from both Pre and Post-2 
assessments, and entered in the analyses of specific treatment effects on neurophysiological 
parameters of Cue processing. The CPT-dropouts with available Pre-assessment data did not 
differ in age (F(1, 101)=0.19, p=.66, part. η2<.01) or sex-ratio (χ2(1)=1.48, p=.22, see Table 1) 
nor behavioral ratings from those participants who were included in the analysis.  
Statistics 
We analyzed the relationship between ADHD symptom-ratings and CPT Performance and ERP 
components evoked by Cue-Processing. We conducted linear mixed-effects models in R with 
a maximum likelihood fit [lme4 package; (Bate, Mächler, Bolker & Walker, 2015)] where Cue-
P3 and -CNV at Fz, Cz, and Pz were set as within-subject factor, fixed effects and were mean-
centered. Age, medication at pre-assessment, site and sex were added as possible covariates, 
and intercepts were set as random factors. We repeated this analysis with CPT behavioral 
performance; Hit rate, reaction time, reaction time variability, omission, and commission errors 
which were mean-centered, and included as fixed effects. Additionally, the same analysis was 











Second, neurophysiological and clinical changes from Pre to Post-2 were evaluated in separate 
GLMs (SPSS 26.0.0.1) with between-subject factor Treatment (SCP-NF vs. EMG-BF) and 
within-subject factor Change Δ (Pre vs Post-2 treatment). For predicting treatment outcome we 
performed a linear mixed-effects models as described above with the change between Post-2 
minus Pre for all (Δ) FBB-HKS scales as dependent variables and Age, Sex, and baseline Cue-
P3 and CNV as predictors. These analyses were additionally repeated with the CPT 
performance variables and with clinical changes rated by teachers.  
Further, we assessed the specificity of the SCP-NF using a linear mixed model with the 
differences Δ between Pre and Post-2 for the FBB-HKS scales as dependent variables and Δ 
Cue-P3 and – Δ CNV (Post-2 minus Pre) as predictors, controlling for Age and Sex. Significant 
interactions were further explored applying a Johnson-Neyman simple slope analysis (R 
package “interactions”, Long JA (2019)).  
Finally, we evaluated the role of CNV-changes in the SCP-NF group only, by classifying 
participants into SCP-NF CNV-responders or CNV-non-responders aiming at identifying 
baseline differences in the CNV-responder group. To meet the criteria of CNV-responder 
participants had to show a CNV improvement at Post-2 assessment. We compared both groups 
by means of an ANOVA or chi-square when appropriate for all above-mentioned variables.  
Results 
At Pre-assessment no group differences were found in behavioural ratings with the FBB sores 
(all p>.56, part. η2<.01). CPT performance was similar in both groups with the exception of a 
slightly lower hit-rate in patients receiving EMG-BF (F(1,101)=4.77, p=.03, part. η2=.05, see 
Table 1). The Cue-P3 and –CNV with the expected maxima at parietal and centro-parietal sites 
showed no significant differences between treatment groups (see Table 1 for data from the total 
sample with Pre-assessment available). 
 
Association of neurophysiological parameters of Cue-Processing and 
symptom severity at baseline 
We found a significant negative association between the Cue P3 amplitude at its topographical 
Pz maximum with the parent-rated FBB global scale (F(1,103)=4.66, p=0.031), with 
hyperactivity (F(1,103)=5.38, p=0.020) and impulsivity (F(1,103)=5.23, p=0.022), but not with 
inattention (F(1,103)=0.11, p=0.730, see table 2 and figure 2), which was not present for teacher 
ratings (all p>.273, see supplement S1). No significant associations were found for the CNV 
amplitude at baseline with any of the variables.  
########################################################################### 














Insert Figure 2 about here 
########################################################################### 
 
With regard to the behavioral performance in the CPT task, no significant associations were 
found with the parent ratings (all p>.217, supplement S2). However, teacher ratings showed 
significant associations with lower hit rates, lower reaction time, and higher reaction time 
variability (RTV) which were associated with higher global symptom severity, and inattention. 
Further, hyperactivity was associated with RTV only (for details see supplement S3).  
Evaluation of overall treatment effects 
The comparison between Pre and Post-2 assessment was based on sub-samples of patients with 
available Pre and Post-2 assessment data that received SCP-NF (N=40) or EMG-BF (N=37) 
training. The groups did not differ in age (F(1,75)=0.71, p=.40, part. η2<.01) or sex-ratio 
(χ2(1)=2.60, p=.11, see Table 3). Exploratory multivariate analyses of FBB-ratings from parents 
(available from N=41 receiving SCP-NF and N=43 that got EMG-BF), and age from Pre-
assessment and between-subject factor Group and CPT-Dropout (CPT data available vs. 
unavailable at Post-2) revealed no main effects of CPT-Dropout (Wilk’s λ=.95, F(5,76)=0.89, 
p=.49, part. η2=.06), Group (Wilk’s λ=.99, F(5,76)=0.10, p=.99, part. η2<.01) and no interaction 
of Group×CPT-Dropout (Wilk’s λ=.99, F(5,76)=0.23, p=.95, part. η2=.02).  
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Parents in both groups rated improvements on all symptom scales (see Figure 3 for confidence 
intervals with p=.05), with higher improvement in Global- and inattention-scores following 
SCP-NF (both F(1,65)≥5.00, p=.03, part. η2≥.07). Teacher ratings also revealed improvements 
in both intervention groups, but no superiority of SCP-NF (all F(1,65)<1, p>.64, part. η2<.01). 
This result closely resembles the outcome from the total sample of the study as reported by 
Strehl et al. (2017). 
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Performance data was missing for 3 subjects that received SCP-NF and 3 with EMG-BF 
training. Reaction times were slower at Post-2 assessment (Time: F(1,79)=30.5, p<.01, part. 
η2=.28), and did not differ between groups (Group: F(1,79)=0.37, p=.55, part. η2<.01 and 
Time×Group: F(1,79)=0.22, p=.64, part. η2<.01, see Table 3). 
Reaction-Time Variability 
Reaction-Time Variability increased from Pre to Post-2 assessments (Time: F(1,79)=37.12, 
p<.01, part. η2=.32) similarly for both groups (Group: F(1,79)=0.02, p=.88, part. η2<.01 and 
Time×Group: F(1,79)=0.09, p=.76, part. η2<.01). 
########################################################################### 




Hit-Rate decrease in those receiving SCP-NF compared to EMG-BF (F(1,75)=4.80, p=.03, part. 
η2=.06), while Commission-Errors remain similarly stable in both groups (F(1,75)=0.38, p=.54, 
part. η2<.01). 
Cue-P3 
The Cue-P3 amplitude was tested at its Pz maximum and was smaller at Post-2 assessment 
(Time: F(1,75)=8,4 p<.01, part. η2=.10). No group differences in change from Pre- to Post-2 
assessment were significant (Time×Group: F(1,75)<0.01, p=.97, part. η2<.01, see Table 3 and 
Figure 5). 
Cue-CNV 
The slow-wave CNV mean amplitude tested at its Cz maximum was reduced in the Post-2 
compared to the Pre-assessment (Time: F(1,75)=19.0, p<.01, part. η2=.20). No differences 
between intervention groups in CNV-change were significant (Time×Group: F(1,75)=0.37, 
p=.55, part. η2<.01).  
########################################################################### 
Insert Figure 5 about here 
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Prediction of clinical outcome with neurophysiological and 
neuropsychological parameters at baseline  
Regarding CPT performance, an interaction emerged with group and reaction time (RT) as a 











teacher-rated impulsivity (F(1,80)=5.58, p=.018). Post-hoc analysis showed that the effect was 
driven by the EMG-BF group for parent-rated inattention improvement (t=-2.61, p=.01) and 
not for the SCP-NF group (t=0.36, p=.72), indicating that faster RT at baseline predicted 
significant improvement of inattention in the EMG-BF group (Figure 6 A). However, faster 
RT at baseline predicted improvement of impulsivity rated by teachers in the SCP-NF group 
(t=-2.94, p<.001) but not in the EMG-BF group (t=.69, p=.49) (Figure 6 B). A trend was also 
seen for RT-Variability predicting inattention rated by parents (F(1,80)=3.49, p<.062) 
irrespective of groups (Figure 6 C). Moreover, more commission errors predicted 
improvements following SCP-NF and EMG-BF in parent-rated hyperactivity (F(1,80)=4.33, 
p=.037,see Figure 6 D). 
Cue-related activity at baseline showed a group-specific predictive value for Cue-P3 at Pz 
[interaction with group, F(1,67)=6.62, p=.010]. Post-hoc analyses suggested that larger Cue-P3 
tended to predict more improvements in teacher-rated inattention for those receiving SCP-NF 
(t=1.94, p=.06), but in contrast less improvement following EMG-BF (t=-1.82, p=.07) (Figure 
6 E). Furthermore, an interaction emerged between group and Cue-CNV at Cz which predicted 
improvement in teacher-rated inattention (F(1,67)=5.95, p=.015). This interaction was driven by 
the EMG-BF group (t=-2.43, p=.02) indicating that a larger (that is more negative) CNV at Cz 
at baseline predicted decrease of teacher-rated inattention symptoms (Figure 6 F). 
########################################################################### 
Insert figure 6 about here 
########################################################################### 
 
Specific association of clinical improvements 
Mixed model analyses showed a significant interaction between group and CNV changes from 
Pre to Post-2 assessment at Pz (F(1,77)=4.44, p=.03), and as a trend also at Cz, F(1,77)=2.81, 
p=.07) for parent-rated improvement of inattention. Further, a significant interaction between 
group and CNV changes at Cz (F(1,77)=4.99, p=.03, and as a trend also at Pz, F(1,77)=3.51, p=.07) 
was found for improvement of impulsivity. Separate post-hoc analyses for each group yielded 
a trend for an association between increased CNV and improved inattention in the SCP-NF 
group (t=-1.953, p=.051, but not for impulsivity, t=0.956, p=.34). This pattern suggests that 
those participants in the SCP-NF group who improved their CNV amplitude from Pre- to Post-
2 assessment, improved more on parent-rated inattention, which was not seen in those patients 
receiving EMG-BF. For details see table 4 and Figure 7. 
########################################################################### 














Insert Figure 7 about here 
########################################################################### 
 
Concerning the teacher ratings, group interacted with the CNV change at Cz for hyperactivity 
improvement (F(1,63)=4.94, p=.026). In line with the parent ratings, this association suggests 
that the increase of the CNV was differently associated with clinical improvement in the two 
groups. The association was significant for SCP-NF group but not for the EMG-BF group in a 
separate post-hoc analysis for each group (SCP-NF t=-2.20, p=.03, and EMG-BF t=.83, p=.41). 
Nevertheless, no significant association was found for the global score or for inattention rated 
by teachers. Additionally, an increase of the P3 at Pz for Pre to Post-2 was also associated with 
clinical improvement, but only for impulsivity rated by teachers (p=.03). For details see 
Supplement S4.  
Differences between CNV- Responders and non-Responders 
37,5% percent (n=15) of the participants were classified as CNV-Responders, whereas 25 were 
non-responders. The responder group showed reduced hit rates (F(1,39)=4.55, p=.039) and a 
reduced CNV at baseline (F(1,39)=12.834, p<.001). All the other variables did not differentiate 
between CNV-responders and non-responders (Table 5).  
########################################################################### 
Insert Table 5 about here 
########################################################################### 
Discussion 
Neurofeedback can be an effective training for treating ADHD. Identifying those patients that 
may benefit most reliably would make an important step towards improving its effectiveness, 
but evidence that allows predicting treatment outcome early on is currently rare. 
To this end, we investigated the predictive value of ERP and behavioral markers of attention 
and anticipation during a sustained attention task by investigating the possible underlying 
mechanisms in a large multicenter randomized controlled trial. We further assessed the 
specificity of neurophysiological changes after SCP-NF treatment. As neurophysiological 
variables, we chose the ERP components Cue-P3 and -CNV, which showed in previous studies 
a predictive value and specific changes after SCP-NF. Effects were evaluated through a cued 
CPT. 
As a main outcome, we found that the Cue P3 at its parietal (Pz) maximum was negatively 
associated with ADHD core symptoms except for inattention. The CNV did not show any 
significant association with baseline symptom severity. These findings are partially in line with 











Cue P3 than for the CNV (Kaiser et al., 2020). Furthermore, we did not find any significant 
association between ERP components and the baseline ratings of teachers. This might be 
related to the reduced symptom severity rated by teachers (Sollie, Larsson, & Morch, 2013; 
Strehl et al., 2017) and that parent ratings might be more sensitive to the children’s symptoms 
(Cheung et al., 2016; Du Rietz et al., 2016). Interestingly, behavioral performance of the CPT 
task was associated with teacher ratings only. Specifically, reduced hit rates, slower reaction 
times and higher RTV were associated with global symptoms and inattention rated by teachers 
at baseline. Additionally, hyperactivity was further associated with higher RTV. This result is 
in line with the current literature (for review see Kofler et al., 2013). Strikingly, these 
associations with behavioral markers of attention were only found for teachers and not for 
parent ratings. We speculate that the CPT task might resemble more a classroom-like setting 
in which teachers are more sensitive.  
Concerning the predictive value of ERP and behavioral markers of attention and anticipation, 
various group interactions emerged. Faster reaction time at baseline predicted more clinical 
improvement rated by parents´ for the inattention subscale in the EMG-BF group, and more 
impulsivity improvement rated by teachers´ in the SCP-NF group. More commission errors 
predicted higher parent-rated hyperactivity improvement regardless of group. Faster reaction 
time at baseline was also predictive for teacher rated impulsivity in the SCP-NF group. 
Although these results are exploratory and heterogeneous, they might help to understand who 
is more responsive to SCP-NF. With regard to neurophysiological activity, we could not 
replicate the findings of (Wangler et al., 2011). Contrary to our expectations, higher CNV at 
baseline did only predict clinical improvement in the EMG-BF control group, but not so for 
the SCP-NF group. Instead, a larger Cue P3 at baseline tended to predict inattention 
improvement rated by teachers in the SCP-NF group only.  
Regarding specific effects after SCP-NF, we failed to support earlier findings of increased 
CNV amplitude at a group level after SCP-NF training during a CPT task (Heinrich et al., 2004; 
Wangler et al., 2011). However, the CNV decrease at Pz and Cz interacted significantly with 
group, showing that the increase of the CNV negativity was associated with more clinical 
improvements for inattention and impulsivity symptoms rated by parents in the SCP-NF group. 
This might suggest a specific effect for those who were able to recruit more attentional 
resources at the Post-2 assessment. In general and at a group mean level, our results might point 
to a rather unspecific component of effects observed after both the SCP-NF and EMG-BF 
training, but when taking into consideration the CNV changes from Pre to Post-2, a group by 
CNV interaction emerged.. A similar effect, but restricted to the hyperactivity subscale, was 
also found for teacher ratings., which may indicate a specific effect after SCP-NF. Importantly, 
and despite the smaller sample size of the analyzed group, the clinical outcome of this sub-
sample for our neurophysiological outcomes resembled the findings of the whole sample 
(Strehl et al., 2017), suggesting that it was not biased.  
Contrary to our expectations, performance and electrophysiological parameters of Cue 
processing were diminished at Post-2 assessment after both SCP-NF and EMG-BF 
interventions. This was eminent in slower and more variable reaction times to cued targets and 











prolonged laboratory sessions that occupied a considerable part of our patient’s free time rather 
than some fancy elaborated neural efficacy after treatments. These findings are in line with the 
results of Doehnert et al. (2008) who argued that a repetitive and to the patients probably boring 
test battery without sufficient motivation or reward salience might be associated with reduced 
engagement and consequently less functional neurophysiological activity. Additionally, one 
SCP-NF study with healthy adults obtained similarly diminished CNV, but importantly in light 
of stable or even better CPT-performance after 8 NF sessions. As discussed by Gevensleben et 
al. (2014), under these circumstances the reduced CNV at post-assessment might therefore 
reflect less effort needed after NF training to complete the same task with comparable 
performance. We thus consider in line with Doehnert et al. (2008) that mainly motivational 
difficulties might be responsible for the limited CPT outcome at Post-2 assessment. 
As a new finding, our data indicated that parent ratings of improvements in attention, 
impulsivity and teacher ratings of hyperactivity were associated with improvements in Cue-
CNV amplitude only in the group receiving SCP-NF; suggesting a possibly specific mode of 
action. Further exploratory analysis showed that those participants who improved their CNV 
had lower hit rates and reduced CNV at baseline. This might suggest that these participants 
might benefit more from the SCP-NF treatment and underlines recent efforts to individualize 
NF training (Bioulac et al., 2019). However, these results should be interpreted with caution 
since the responder group comprised only 15 participants and require replication before 
definitive conclusions or even suggestions towards an individualized NF treatment protocol 
can be given. 
 
Limitations 
The generalization of our results is limited by different factors among which we consider as 
most important the reduced quality of EEG data and therefore a higher CPT-Dropout rate of 
participants. Only 58% of the complete sample could be analyzed. The main reasons were 
insufficient quality of EEG data but missing measurements as well. It is worth noting, that the 
quality of the CPT assessment might suffer from the possible lack of motivation due to the high 
amount of EEG assessments and tests.  
 
Conclusion 
Across clinical and neurophysiological outcomes, some neurophysiological and behavioral 
markers of attention at baseline were associated with symptom severity. Importantly, we found 
that aspects of CPT Performance, Cue-P3 and -CNV  predicted specific treatment outcomes 
which may help to tailor the treatment to individuals in the future. Moreover, we observed 
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Figure 1. Study Characteristics 
  
a) The study flow chart shows the sequence of assessments (red), medication wash-out 
(blue) and the training block (green). The assessment started with a Screening followed 
by medication washout and Pre-Tests. The trainings were performed within 3 months, 
followed by a Post-1 test. After medication washout for four weeks, the Post-2 testing 
was conducted, followed five months later by the Follow-up assessment. The 
comparison between Pre and Post-2 may indicate specific effects of NF, and the 
comparison Post-2 with Follow-up tests for stability of effects. Adapted from Holtmann 
et al. (2014). 
b) The CPT consists of a sequence of briefly presented letters (stimulus onset of 150 ms 
with a stimulus-onset asynchrony of 1650 ms). Only if the Cue (“O”) is followed by 
the Target (“X”), a button-press is required. In particular, cued nontargets (red) require 
inhibiting a prepared response, while cued targets (blue) require execution. Distractors 
never require preparation or response (adapted from Albrecht et al. (2013)). The ERP 
waveforms and maps illustrate similar to Cues (black) and Distractors (red) at Pre-
assessment in the subsamples receiving SCP-NF (N=50, left) and EMG-BF (N= 53, 
right). The Cue-P3 has a parietal maximum, and the Cue-CNV a centro-parietal 
minimum maximum in both groups. 
c) From the total sample tested with the CPT before SCP-NF or EMG-BF were 
















 Diagnosis of ADHD










• within 3 months
• 25 sessions á 160 trials

































Main outcome: Specific effects of Neurofeedback?






































c) Included Sample and Dropouts
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included in the prediction analysis. Of these, again almost ¾ hat also data from Post-




Figure 2. Baseline measurements. ADHD symptoms and Cue P3 at Pz 
 
Parent ratings and Cue P3. A) Association between Cue P3 and Global scale. B) Inattention 











Figure 3: Changes in behavioral ratings 
 
Following treatment, parents rated reduced symptom scores changes (Δ) for all FBB-HKS 
scales. For global and inattention scores improvement were significantly larger after SCP-NF 
than after EMG-BF. Teachers also rated improvements for the global and inattention scales, 






























Figure 4: Changes in Continuous Performance Test Performance from pre to post 2 
 
Means and confidence intervals (p=.05) of changes (Δ) from Pre- to Post-2 assessments of the 
main performance parameters. Reaction times (RT) and RT-variability (RT-SD) were 
significantly elevated in the Post-2 compared to Pre-assessment. As a trend, Hit-Rate worsened 








































Figure 5. Event-related Potentials of Cue-Processing: Preparation and Anticipation 
 
Analyses of ERPs associated with Anticipation and Preparation.  A) In Post-2 compared to Pre-
assessment, both Cue-P3 and –CNV had significantly diminished amplitudes (i.e. changes (Δ) 
for Cue-P3 were of negative and Cue–CNV were of positive amplitude), which was similarly 
the case in both groups (see confidence intervals with p=.05 at the respective Cz and Pz 
maxima).B) Exploratory T-maps of the within-subject change Post-2 minus Pre from Cue-P3 
and -CNV: the difference between Post-2 minus Pre-assessment in Cue-P3 amplitude was 
significantly negative at posterior sites and more positive at frontal sites, while the difference 
in CNV amplitudes was significantly positive over central sites. C) Exploratory T-Maps of the 
between-subject comparison between SCP-NF and EMG-BF of Change (Post-2 minus Pre): no 
differences between interventions were significant. 
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Table 1: Sample characteristics, behavioral ratings and CPT Performance at Pre-assessment 







 (N=50) (N=53)  
Measure  Mean (SD)  Mean (SD)   
       
Age (in years)a  8.70 (0.89)  8.6 (0.90)  F(1,101)=0.19, p=.66, part. η2<.01 
Sex (% male)b  80%  89%  Χ2(1)=1.48, p=.22 
Medication  38%  45%  Χ2(1)=0.56, p=.45 
 
 
    
 
FBB-HKS (parent)a      
Total  1.76 (0.41)  1.73 (0.47)  F(1,85)=0.11, p=.75, part. η2<.01 
Attention  2.01 (0.48)  1.95 (0.52)  F(1,85)=0.34, p=.56, part. η2<.01 
Hyperactivity  1.44 (0.67)  1.46 (0.71)  F(1,85)=0.02, p=.89, part. η2<.01 
Impulsivity  1.76 (0.69)  1.71 (0.79)  F(1,85)=0.08, p=.78, part. η2<.01 
      
FBB-HKS (teacher)a      
Total  1.42 (0.66)  1.40 (0.74)  F(1,85)=0.02, p=.89, part. η2<.01 
Attention  1.68 (0.75)  1.68 (0.74)  F(1,85)<0.01, p=.99, part. η2<.01 
Hyperactivity  1.09 (,.81)  1.06 (0.89)  F(1,85)=0.03, p=.86, part. η2<.01 
Impulsivity  1.42 (0.95)  1.35 (1.03)  F(1,85)=0.10, p=.76, part. η2<.01 
      
CPT: Performance      
Hit-RT  531 (107)  511 (93)  F(1,101)=0.98, p=.32, part. η2=.01 
Hit-RT-SD  181 (73)  169 (70)  F(1,101)=0.63, p=.43, part. η2<.01 




3.3 (6.7)  3.5 (6.2)  
F(1,101)=0.04, p=.85, part. η2<.01 
      
CPT: Cue-P3      
Pz  9.7 (5.5)  10.0 (4.9)  F(1,101)=0.09, p=.76, part. η2<.01 
      
CPT: Cue-CNV      
Cz  -2.9 (2.6)  -3.1 (2.1)  F(1,101)=.18, p=.67, part. η2<.01 
    
a FBB-HKS parents and teacher ratings are available for N=43 participants who received SCP-













Table 2. Association between neurophysiological markers of attention and baseline symptom severity. 
FBB Global scale FBB Inattention FBB Hyperactivity FBB Impulsivity 
Predictors Estimates CI p Predictors Estimates CI p Predictors Estimates CI p Predictors Estimates CI p 
(Intercept) 1.03 -0.09 - 2.15 0.076 (Intercept) 1.01 
-0.24 - 
2.26 
0.112 (Intercept) 0.90 
-0.75 - 
2.55 




Age 0.074 -0.03 - 0.18 0.169 Age 0.07 
-0.05 - 
0.19 
0.234 Age 0.08 
-0.07 - 
0.24 




Gender 0.024 -0.21 - 0.26 0.843 Gender 0.18 
-0.09 - 
0.44 
0.187 Gender -0.06 
-0.41 - 
0.29 




Site 0.022 -0.05  - 0.09 0.530 Site 0.01 
-0.07 - 
0.09 
0.878 Site 0.00 
-0.10 - 
0.11 

























CNV at Fz -0.01 -0.04 - 0.03 0.720 CNV at Fz 0.01 
-0.03 - 
0.04 
0.658 CNV at Fz -0.03 
-0.08 - 
0.02 




CNV at Cz -0.01 -0.05 - 0.04 0.783 CNV at Cz 0.04 
-0.02 - 
0.09 
0.172 CNV at Cz -0.05 
-0.12 - 
0.02 




CNV at Pz 0.01 -0.03- 0.05 0.702 CNV at Pz -0.01 
-0.06 - 
0.03 
0.594 CNV at Pz 0.03 
-0.03 - 
0.09 




CUE P3 at Fz -0.01 -0.03 - 0.01 0.225 CUE P3 at Fz 0.01 
-0.02 - 
0.03 
0.534 CUE P3 at Fz -0.03 
-0.06 - 
0.00 




CUE P3 at Cz 0.01 -0.02 - 0.03 0.684 CUE P3 at Cz -0.00 
-0.03 - 
0.03 
0.960 CUE P3 at Cz 0.01 
-0.03 - 
0.04 




CUE P3 at Pz -0.02 
-0.04 - -
0.00 
0.031 CUE P3 at Pz -0.00 
-0.03 - 
0.02 
0.730 CUE P3 at Pz -0.03 
-0.06 - -
0.01 


















Table 3: Treatment-Effects (Change from Pre to Post-2 assessment) 







 (N=40) (N=37) (Group×Time) 
Change (Post-2 - Pre)  Mean (SD)  Mean (SD)   
       
Age (in years)a  8.74 (0.93)  8.6 (0.92)  F(1,75)=0.71, p=.40, part. η2<.01 
Sex (% male)b  75%  89%  Χ2(1)=2.60, p=.11 
       
FBB-HKS (parent)a       
Global  -0.48 (0.39)  -0.25 (0.45)  F(1,65)=5.00, p=.03, part. η2=.07 
Inattention  -0.55 (0.51)  -0.25 (0.53)  F(1,65)=5.28, p=.03, part. η2=.08 
Hyperactivity  -0.47 (0.45)  -0.32 (0.57)  F(1,65)=1.28, p=.26, part. η2=.02 
Impulsivity  -0.35 (0.54)  -0.12 (0.64)  F(1,65)=2.06, p=.11, part. η2=.04 
       
FBB-HKS (teacher)b       
Global  -0.20 (0.61)  -0.21 (0.49)  F(1,53)<0.01, p=.96, part. η2<.01 
Inattention  -0.26 (0.54)  -0.19 (0.59)  F(1,53)=0.22, p=.64, part. η2<.01 
Hyperactivity  -0.12 (0.87)  -0.18 (0.55)  F(1,53)=0.09, p=.76, part. η2<.01 
Impulsivity  -0.22 (0.89)  -0.31 (0.77)  F(1,53)=0.14, p=.71, part. η2<.01 
       
CPT-Performance       
Hit-RT  65 (111)  50 (79)  F(1,75)=0.47, p=.50, part. η2<.01 
Hit-RT-SD  72 (103)  51 (79)  F(1,75)=0.94, p=.34, part. η2=.01 




-0.8 (3.5)  -1.5 (5.1)  
F(1,75)=0.38, p=.54, part. η2<.01 
       
CPT: Cue-P3       
Pz  -1.8 (5.3)  -1.8 (5.4)  F(1,75)<0.01, p=.97, part. η2<.01 
       
CPT: Cue-CNV       
Cz  1.1 (2.8)  1.5 (2.5)  F(1,75)=0.37, p=.55, part. η2<.01 
       
a available for N=35 with SCP-NF and N=32 with EMG-BF 































Δ indicates changes between Pre and Post-2 assessments. Negative values for clinical changes indicate improvement at Post-2. A) 
Reaction time (RT) showed a significant group interaction (p=.018). Faster RT at baseline predicted significant inattention 
improvement in the EMG-BF group only (p=.01). B) Faster RT at baseline predicted impulsivity improvement rated by teachers, 
particularly for the SCP-NF group  (p<.001) and not for the EMG-BF (p=.49). C) Reaction time variability (RTV) showed a trend 
for group interaction. D) More commission errors predicted symptom improvement for parent ratings. E) Larger Cue-P3 predicted 












Table 4 – Mixed model for CNV changes and clinical changes 
FBB Global scale (Δ) FBB Inattention (Δ) FBB Hyperactivity (Δ) FBB Impusivity (Δ) 




0.831 (Intercept) 0.08 
-1.43 - 
1.58 
0.921 (Intercept) -0.17 
-1.64 - 
1.29 







0.458 Age 0.03 
-0.11 - 
0.18 
0.636 Age 0.03 
-0.10 - 
0.17 







0.222 Gender 0.13 
-0.20 - 
0.45 
0.447 Gender 0.15 
-0.17 - 
0.47 




Medication at pre -0.02 
-0.23 - 
0.19 
0.880 Medication at pre -0.01 
-0.26 - 
0.24 
0.949 Medication at pre 0.05 
-0.19 - 
0.30 







0.004 Group -0.33 
-0.57 - 
-0.08 
0.009 Group -0.21 
-0.45 - 
0.03 




Δ CNV at Fz 0.02 -0.02 - 
0.06 
0.235 Δ CNV at Fz 0.05 -0.00 - 
0.09 
0.057 Δ CNV at Fz 0.01 -0.03 - 
0.06 
0.581 Δ CNV at Fz -0.01 -0.06 - 
0.05 
0.804 
Δ CNV at Cz -0.02 -0.08 - 
0.05 
0.607 Δ CNV at Cz -0.05 -0.13 - 
0.03 
0.235 Δ CNV at Cz -0.03 -0.10 -
0.05 
0.469 Δ CNV at Cz 0.07 -0.02 -
0.16 
0.112 
Δ CNV at Pz 0.03 -0.03-
0.08 
0.368 Δ CNV at Pz 0.06 -0.01 - 
0.13 
0.080 Δ CNV at Pz 0.02 -0.05 - 
0.09 
0.546 Δ CNV at Pz -0.05 -0.13 - 
0.03 
0.236 
Δ CUE P3 at Fz -0.02 -0.05 - 
0.01 
0.256 Δ CUE P3 at Fz -0.01 -0.05 - 
0.03 
0.521 Δ CUE P3 at Fz -0.03 -0.06 - 
0.01 
0.168 Δ CUE P3 at Fz -0.02 -0.06 - 
0.03 
0.386 
Δ CUE P3 at Cz 0.00 -0.04 - 
0.04 
0.958 Δ CUE P3 at Cz -0.01 -0.06 - 
0.03 
0.560 Δ CUE P3 at Cz 0.03 -0.01 - 
0.07 
.0189 Δ CUE P3 at Cz -0.01 -0.06 - 
0.04 
0.663 
Δ CUE P3 at Pz -0.00 -0.04 - 
0.03 
0.801 Δ CUE P3 at Pz 0.01 -0.02 - 
0.05 
0.491 Δ CUE P3 at Pz -0.01 -0.05 - 
0.02 
0.484 Δ CUE P3 at Pz -0.03 -0.07 - 
0.01 
0.188 
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Figure 7. CNV and clinical changes  
 
 
SCP-NF: Slow cortical potential neurofeedback, EMG-BF: Electromyogram biofeedback. Δ 
indicates changes between Pre and Post-2 assessments. CNV; Contingent negative variation. 
Negative values indicate larger (that is more negative) CNV at Post-2. Negative values for 
clinical changes indicate improvement at Post-2. ns; not significant. A) No association between 
Δ CNV and Δ global scale. B) Significant group x CNV at Pz interaction (p=.03). Only the 
SCP-NF group showed an association with larger CNV at post-2 and inattention improvement. 
C) No association between Δ CNV and Δ hyperactivity. D) Significant group x CNV at Cz 
interaction (p=.03). Only the SCP-NF group showed an association with larger CNV at post-2 


















Table 5.  Baseline differences between SCP-NF responders and non-responders 








 (N=15) (N=25)  
Measure  Mean (SD)  Mean (SD)   
       
Age (in years)a  8.66 (0.88)  8.7 (0.97)  F(1,39)=1.36, p=.71 
Sex (% male)b  80%  89%  Χ2(1)=0.00, p=1 
 
 
    
 
FBB-HKS (parent)      
Total  1.79 (0.45)  1.75 (0.48)  F(1,39)=0.09, p=.55 
Attention  1.91 (0.45)  2.02 (0.44)  F(1,39)=0.433, p=.76 
Hyperactivity  1.57 (0.57)  1.49 (0.72)  F(1,39)=0.134, p=.51 
Impulsivity  1.90 (0.67)  1.60 (0.63)  F(1,39)=1.90, p=.17 
      
FBB-HKS (teacher)      
Total  1.30 (0.78)  1.54 (0.64)  F(1,33)=0.93, p=.34 
Attention  1.49 (0.65)  1.87 (0.78)  F(1,33)=2.09, p=.15 
Hyperactivity  1.17 (1.00)  1.06 (0.83)  F(1,33)=0.115, p=.73 
Impulsivity  1.12 (0.97)  1.61 (0.97)  F(1,33)=1.95, p=.17 
      
CPT: Performance      
Hit-RT  530 (104)  515 (116)  F(1,39)=0.16, p=.69 
Hit-RT-SD  167(100)  174 (55)  F(1,39)=0.09, p=.75 




0.933 (1.43)  1.08 (1.84)  
F(1,39)=0.69, p=.79 
      
CPT: Cue-P3      
Pz  10.54 (6.00)  8,99 (4.9)  F(1,49)=0.72, p=.379  
      
CPT: Cue-CNV      
Cz  -1.13 (2.01)  -4.25 (2.48)  F(1,39)=23.10, p<.001  
    
RE = Responder and non –RE = non-responder. RE were considered if participants showed a 
CNV improvement at Post-2 assessment. 
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